toto slot

toto togel 4d

situs togel

10 situs togel terpercaya

situs togel

10 situs togel terpercaya

link togel

situs toto

situs togel terpercaya

bandar togel online

10 situs togel terpercaya

bo togel terpercaya

bo togel terpercaya

10 situs togel terpercaya

situs toto

situs togel

https://rejoasri-desa.id

https://www.eksplorasilea.com/

https://ukinvestorshow.com

https://advisorfinancialservices.com

https://milky-holmes-unit.com

RTP SLOT MAXWIN

2.5 Billion People in 130 Countries are without COVID-19 Vaccines- WHO

2 Min Read
WHO, Yobe Govt begin house-to-house community awareness on COVID-19 in Northeast

 

The World Health Organisation (WHO) says three quarters of all COVID-19 vaccinations were only in 10 countries, accounting for almost 60 per cent of global Gross Domestic Product (GDP).

“Around 130 countries, with 2.5 billion people, are yet to administer a single dose”, WHO Director- General, Dr Tedros Ghebreyesus said at a regular press briefing on COVID-19, in Geneva, on Friday.

“On Wednesday, COVAX published its forecast for the distribution of vaccines to participating countries. Countries are ready to go, but the vaccines aren’t there. We need countries to share doses, once they have finished vaccinating health workers and older people.

“We also need a massive scale-up in production. Manufacturers can do more: having received substantial public funding, we encourage all manufacturers to share their data and technology to ensure global equitable access to vaccines.’’

Ghebreyesus repeated his call on companies to share their dossiers with WHO faster and more fully than they have been doing, so that the oragnisation would review them for emergency use listing.

Similarly, he called on companies to emulate last week’s announcement by French pharmaceutical giant Sanofi that it would make its manufacturing infrastructure available for the production of the Pfizer/BioNTech vaccine.

READ ALSO :NERC: More than 60 per cent of consumers on estimated billing

“Companies can also issue non-exclusive licenses to allow other producers to manufacture their vaccine – a mechanism that has been used before to expand access to treatments for HIV and hepatitis C,’’ he said.

Share this Article